Cargando…
When Should We Start Sodium–Glucose Co-transporter Inhibitors in Patients with Heart Failure? The Importance of Early Intervention
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Radcliffe Cardiology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10345959/ https://www.ncbi.nlm.nih.gov/pubmed/37456773 http://dx.doi.org/10.15420/ecr.2022.62 |
_version_ | 1785073207648190464 |
---|---|
author | Iguchi, Moritake Wada, Hiromichi Martínez, Felipe Hasegawa, Koji |
author_facet | Iguchi, Moritake Wada, Hiromichi Martínez, Felipe Hasegawa, Koji |
author_sort | Iguchi, Moritake |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10345959 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Radcliffe Cardiology |
record_format | MEDLINE/PubMed |
spelling | pubmed-103459592023-07-15 When Should We Start Sodium–Glucose Co-transporter Inhibitors in Patients with Heart Failure? The Importance of Early Intervention Iguchi, Moritake Wada, Hiromichi Martínez, Felipe Hasegawa, Koji Eur Cardiol Heart Failure Radcliffe Cardiology 2023-06-07 /pmc/articles/PMC10345959/ /pubmed/37456773 http://dx.doi.org/10.15420/ecr.2022.62 Text en Copyright © 2023, Radcliffe Cardiology https://creativecommons.org/licenses/by-nc/4.0/This work is open access under the CC-BY-NC 4.0 License which allows users to copy, redistribute and make derivative works for non-commercial purposes, provided the original work is cited correctly. |
spellingShingle | Heart Failure Iguchi, Moritake Wada, Hiromichi Martínez, Felipe Hasegawa, Koji When Should We Start Sodium–Glucose Co-transporter Inhibitors in Patients with Heart Failure? The Importance of Early Intervention |
title | When Should We Start Sodium–Glucose Co-transporter Inhibitors in Patients with Heart Failure? The Importance of Early Intervention |
title_full | When Should We Start Sodium–Glucose Co-transporter Inhibitors in Patients with Heart Failure? The Importance of Early Intervention |
title_fullStr | When Should We Start Sodium–Glucose Co-transporter Inhibitors in Patients with Heart Failure? The Importance of Early Intervention |
title_full_unstemmed | When Should We Start Sodium–Glucose Co-transporter Inhibitors in Patients with Heart Failure? The Importance of Early Intervention |
title_short | When Should We Start Sodium–Glucose Co-transporter Inhibitors in Patients with Heart Failure? The Importance of Early Intervention |
title_sort | when should we start sodium–glucose co-transporter inhibitors in patients with heart failure? the importance of early intervention |
topic | Heart Failure |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10345959/ https://www.ncbi.nlm.nih.gov/pubmed/37456773 http://dx.doi.org/10.15420/ecr.2022.62 |
work_keys_str_mv | AT iguchimoritake whenshouldwestartsodiumglucosecotransporterinhibitorsinpatientswithheartfailuretheimportanceofearlyintervention AT wadahiromichi whenshouldwestartsodiumglucosecotransporterinhibitorsinpatientswithheartfailuretheimportanceofearlyintervention AT martinezfelipe whenshouldwestartsodiumglucosecotransporterinhibitorsinpatientswithheartfailuretheimportanceofearlyintervention AT hasegawakoji whenshouldwestartsodiumglucosecotransporterinhibitorsinpatientswithheartfailuretheimportanceofearlyintervention |